• 专利标题:   MOF-AuNRs-NG composite material for simultaneous detection of dopamine, uric acid and vitamin C, comprises materials by weight, where complex is core-shell structure compound taking gold nano-rod as core, and carbon material.
  • 专利号:   CN116037917-A
  • 发明人:   WU D, YANG Y, ZHANG T, XU Y, CHEN M
  • 专利权人:   FIRST AFFILIATED HOSPITAL CHENGDU MEDICA
  • 国际专利分类:   B22F001/054, B22F001/16, B22F009/24, B82Y030/00, B82Y040/00, G01N027/30, G01N027/48
  • 专利详细信息:   CN116037917-A 02 May 2023 B22F-001/16 202349 Chinese
  • 申请详细信息:   CN116037917-A CN11266949 28 Oct 2021
  • 优先权号:   CN11266949

▎ 摘  要

NOVELTY - Composite material comprises 0.1-0.12 pts. wt. metal organic framework (MOF)-gold nanorods (AuNRs) composite, where the MOFAuNRs composite is a core-shell structure composite with gold nanorods as the core and CU-BTC as the shell, and 0.03-0.05 pts. wt. carbon material. USE - The MOF-AuNRs-NG composite material is useful for simultaneous detection of dopamine, uric acid and vitamin C. ADVANTAGE - The composite material has enhanced electro-catalytic activity and electron transfer rate, capable of performing high selectivity to dopamine, uric acid and vitamin C at the same time, high sensitivity detection, and provides a new selection for the detection of the three. DETAILED DESCRIPTION - INDEPENDENT CLAIMS are included for the following: a method for preparing the composite material; and a method for simultaneously detecting dopamine, uric acid and vitamin C.